Rocket Lab (RKLB) closed at $65.71 on October 12, 2026, after trading as high as $75.06 earlier in the month amid volatility. Record Q2 revenue of $234 million (up 62% year-over-year) and a $2.36 billion backlog exceeding 100 missions—bolstered by a 20-launch Electron contract with Synspective—support growth expectations, while the pending Iridium acquisition (shareholder-approved, targeted for mid-2027 close) adds integration upside. Persistent net losses, cash burn tied to Neutron development, and recent analyst target reductions to the $90–$110 range continue to weigh on sentiment. The next earnings release on November 9 may clarify momentum as October trading concludes.